AppId is over the quota
AppId is over the quota
Queen Elizabeth prizewinner: Put pharmacies on chips - tech - 03 February 2015 - New Scientist@import "/css/gridmain.css"; @import "/css/article.css";@import "/css/comlist.css";@import "/data/images/ns/haas/haas.css";/* specific to this article view */#maincol {border-top:solid #A7A7A7 1px; padding-top:15px;}/* Basic commenting CSS*/.combx {margin:10px 0 0 0;padding:10px 20px 10px 10px;}#compnl {border-top:solid #A7A7A7 1px;}/* comment styles for article page only *//* form styles */#comform {margin:20px 50px 20px 10px;}#comform label{width: 90px;text-align: right;}#comform div.userhelp {margin:0 0 2px 115px;}#comform input.textinput, #comform textarea {width:300px;}#comform div.floatclear, #comformlogin div.floatclear {margin-bottom:10px;}#comform input#comcancel{margin:0 10px 0 0;}#comform input#compreview{margin:0 10px 0 0;}#comform textarea {height:95px;}#comformlogin {margin:20px 100px 20px 100px;}#comformlogin label{width: 120px;}#comformlogin input.textinput {width:150px;}#snv_tech a {background: url('/img/bg/snv_tech.jpg') no-repeat; color:#fff;}/* article social media */#sharebtns {width:440px; margin-left:10px; margin-bottom:20px; padding:15px 10px 15px 10px; background:#F2F2F2;}#sharebtns div.floatleft {margin-right:10px;}#sharebtns .stumble {margin-top:1px;}.grpTools img {margin-right:8px; margin-top:9px;}#fblike {margin-top:41px;}
Tech Log inEmailPassword Remember meYour login is case sensitive
I have forgotten my password
Register nowActivate my subscriptionInstitutional loginAthens logincloseMy New ScientistHomeNewsIn-Depth ArticlesOpinionCultureLabGalleriesTopic GuidesLast WordSubscribeDatingLook for Science JobsSPACETECHENVIRONMENTHEALTHLIFEPHYSICS&MATHSCIENCE IN SOCIETYCookies & PrivacyHome|Tech|Health|Opinion|News
Queen Elizabeth prizewinner: Put pharmacies on chips12:03 03 February 2015 byChris BaraniukFor similar stories, visit theInterviewsTopic GuideChemical engineer Robert Langer has won the ?1 million 2015 Queen Elizabeth Prize for Engineering. The prize celebrates the engineers behind "ground-breaking innovation that has been of global benefit to humanity". The announcement was made today at Prince Philip House in London by Lord Browne, chair of the Queen Elizabeth Prize for Engineering Foundation, in the presence of The Duke of York. The queen will present Langer with the prize at Buckingham Palace later this year. Langer's work, particularly on controlled drug delivery, has provided the foundation for treatments for various cancers, diabetes, and many other conditions. He is now developing microchip implants for long-term controlled drug release, an innovation which promises to benefit millions of people. New Scientist spoke to him today. Congratulations on winning this award.Thank you very much. Really I'm honoured, somewhat shocked and humbled by getting it. I think it's a terrific prize, first of all – it's wonderful to see the UK and the queen wanting to do something for engineering. You have made a string of groundbreaking discoveries at the interface between engineering and medicine. How did it all begin?
When I graduated in 1974 there was an oil crisis and I got 20 job offers from oil companies. One of the companies said if you can just increase the yield of this one chemical by 0.1 per cent that would be wonderful – it would be worth billions. I remember thinking that I didn't want to do that. I started looking up other things like education and medicine. I wrote to Judah Folkman, a surgeon in Boston, and he was kind enough to offer me a job. I was the only engineer in the surgery lab; indeed I think I was the only engineer in the whole hospital, and I just saw so many medical problems there that I thought using my engineering background I could solve these problems in different and, I thought, better ways. It was almost like being a kid in an intellectual candy shop. What did your work with Folkman involve?
He had a theory that if you could stop the growth of blood vessels, that might be a way of stopping cancer. I didn't realise, but it was a very controversial theory at the time, and what he wanted me to do was isolate the first substance that could stop blood vessels growing. We had an idea of what such a substance might be but it was a fairly large molecule. Why was the size of this molecule a problem?
Large molecules often have short half-lives when injected into the body, because enzymes degrade them. That was true for this particular molecule too – it was quickly destroyed. I had the idea of developing polymers that could protect the molecule from being destroyed and then release them over whatever period of time you wanted. Now such an approach is used for many therapeutic molecules, for treating cancer, endometriosis, schizophrenia, type 2 diabetes, alcoholism and many other conditions. How did you come up with microchip implants that give people doses of drugs, and what does this approach offer that others don't?
I had the idea while watching a TV show in the 90s about how computer chips were made. I thought you could actually make a chip with little wells with different doses of the same drug or different drugs – you could literally have a pharmacy on a chip. You could release the drugs using a computer program or even manually, by remote control. The clinical trial that we did was for women with osteoporosis. They are supposed to take parathyroid hormone treatment via injections once a day, but the compliance rate is very low. With our technology, there's a little program and it's set so that every night the cover comes off one of the tiny wells containing the drug. You could also use this technology for birth control. No contraceptive implant today lasts for more than five years and no implant can currently be turned on or off whenever the woman wants. We're designing a 17-year implant which the woman may turn off whenever she wants to conceive. Your engineer's perspective has given you a unique view on medicine. Is the field still reluctant to embrace biotechnology?
I think there are always battles to be fought; the natural tendency of many scientists and companies is to be conservative. I also think that's true of grant reviewers. By and large, medicine is embracing new ideas but it's going to be the entrepreneurs, the new professors, the young people who are willing to think outside the box and not necessarily go down a conventional path – I think it's they who will change the future. People have to take bold steps, sometimes, in the beginning. Profile
Robert Langer is a chemical engineer at the Massachusetts Institute of Technology. A renowned inventor, he is the engineer with the most cited research papers ever and a pioneer in bioengineering, drug-delivery technology, tissue engineering and nanotechnology.
If you would like to reuse any content from New Scientist, either in print or online, please contact the syndication department first for permission. New Scientist does not own rights to photos, but there are a variety of licensing options available for use of articles and graphics we own the copyright to.
(Image: Evan McGlinn/NYT/Redux/eyevine)" title=""People have to take bold steps" (Image: Evan McGlinn/NYT/Redux/eyevine)" />"People have to take bold steps" (Image: Evan McGlinn/NYT/Redux/eyevine)ADVERTISEMENTMoreLatest newsTechnology driving rise in abortions of girls in IndiaModernisation is not helping rebalance India's sex ratio. In fact, with 6 million fewer girls born between 2001 and 2011, it is making it worse
Robot firefighter puts out its first blaze
Designed for putting out flames in the cramped quarters of a ship, the SAFFiR robot has had its first successful test
Doc-watcher spots when physicians stop listeningAs screen use becomes ever more ubiquitous in healthcare, doctors may have a hard time focusing on patients during consultations. Lab-in-a-Box aims to help
Living with the algorithms that run our livesMost of us don't understand the software that hones internet searches and our newsfeeds, but we don't need to in order to come to terms with them
see all related stories
MoreLatest newsPluto's evaporating ice leaves it with a blank face18:00 06 February 2015Astronomers hoped Pluto's craters would hold a record of impacts from its neighbours, which are too small to see – a new study dashes those hopes
The secret of the world's largest seed revealedCharismatic coco de mer palm trees of Seychelles seem to be unique among plants in caring for their seedlings with a novel use of leaves
Today on New Scientist17:30 06 February 2015All the latest on newscientist.com: the secret life of your home, breaking the great genetic taboo, ferocious lemming, first stars get younger and more
Both cause and cure for diabetes could be in your gut16:16 06 February 2015Changes in children's gut microbes could signal the onset of type-1 diabetes, but engineered probiotic bacteria could help treat the disease
see all latest news
Most read The island paradise overrun by giant cannibals
Lilac and turquoise are as basic as red and orange Great Barrier Reef set for surprise electoral win Meet – and hear – the world's first bilingual chimps
Mushroom kills with cookie cutter trick
Most read FOLLOW USGet editors' picks in your social streamsThis week's issueSubscribe
For exclusive news and expert analysis, subscribe to New Scientist.
Gain full online accessCurrent issue contentContent of past issues07 February 2015ADVERTISEMENTBack to topLoginEmailPassword Remember meYour login is case sensitive
I have forgotten my password
Register nowActivate my subscriptionInstitutional loginAthens logincloseAbout usNew ScientistSyndicationRecruitment AdvertisingStaff at New ScientistAdvertiseRBI JobsUser HelpContact UsFAQ / HelpDisclaimerTs & CsCookiesPrivacy PolicySubscriptionsSubscribeRenewGift subscriptionStudent SubscriptionMy accountBack issuesThe CollectionThe Anti-ZooLinksSite MapBrowse all articlesMagazine archiveNewScientistJobsThe Last WordRSS FeedsOnline StoreiOS & Android appsLow-bandwidth siteScience JobsSearch all JobsBiology JobsChemistry JobsClinical JobsEarth & Environment JobsEngineering JobsMaths & IT JobsCareers Advice? Copyright Reed Business Information Ltd.View the original article here
0 comments
Post a Comment